Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

Trillium Therapeutics Inc.

Trillium is a research and development company specializing in innovative therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses. These include autoimmune and inflammatory disorders, graft rejection, cancer and chronic viral diseases. TTI identifies early-stage therapeutic candidates with promising preclinical profiles and advances these towards clinical testing, with the primary objective of demonstrating safety and efficacy in humans.

Investment year: 2004
Industry sector: Biotechnology
Region: Ontario
Follow Trillium Therapeutics Inc.